| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |